Literature DB >> 27676643

Electrospun Matrices for Pelvic Floor Repair: Effect of Fiber Diameter on Mechanical Properties and Cell Behavior.

Mahshid Vashaghian1,2, Behrouz Zandieh-Doulabi3, Jan-Paul Roovers2, Theodoor Henri Smit1.   

Abstract

Electrospun matrices are proposed as an alternative for polypropylene meshes in reconstructive pelvic surgery. Here, we investigated the effect of fiber diameter on (1) the mechanical properties of electrospun poly (lactic-co-glycolic acid)-blended-poly(caprolactone) (PLGA/PCL) matrices; (2) cellular infiltration; and (3) the newly formed extracellular matrix (ECM) in vitro. We compared electrospun matrices with 1- and 8 μm fiber diameter and used nonporous PLGA/PCL films as controls. The 8-μm matrices were almost twice as stiff as the 1-μm matrices with 1.38 and 0.66 MPa, respectively. Matrices had the same ultimate tensile strength, but with 80% the 1-μm matrices were much more ductile than the 8-μm ones (18%). Cells infiltrated deeper into the matrices with larger pores, but cellular activity was comparable on both substrates. New ECM was deposited faster on the electrospun samples, but after 2 and 4 weeks the amount of collagen was comparable with that on nonporous films. The ECM deposited on the 1-μm matrices, and the nonporous film was about three times stiffer than the ECM found on the 8-μm matrices. Cell behavior in terms of myofibroblastic differentiation and remodeling was similar on the 1-μm matrices and nonporous films, in comparison to that on the 8-μm matrices. We conclude that electrospinning enhances the integration of host cells as compared with a nonporous film of the same material. The 1-μm matrices result in better mechanical behavior and qualitatively better matrix production than the 8-μm matrices, but with limited cellular infiltration. These data are useful for designing electrospun matrices for the pelvic floor.

Entities:  

Keywords:  PLGA/PCL; electrospinning; fiber diameter; myofibroblastic differentiation; reconstructive pelvic surgery; tissue regeneration

Mesh:

Substances:

Year:  2016        PMID: 27676643     DOI: 10.1089/ten.TEA.2016.0194

Source DB:  PubMed          Journal:  Tissue Eng Part A        ISSN: 1937-3341            Impact factor:   3.845


  7 in total

Review 1.  Mesenchymal stem cell cultivation in electrospun scaffolds: mechanistic modeling for tissue engineering.

Authors:  Ágata Paim; Isabel C Tessaro; Nilo S M Cardozo; Patricia Pranke
Journal:  J Biol Phys       Date:  2018-03-05       Impact factor: 1.365

Review 2.  Recent advances in pelvic floor repair.

Authors:  Emma Mironska; Christopher Chapple; Sheila MacNeil
Journal:  F1000Res       Date:  2019-06-04

3.  Mesopore Controls the Responses of Blood Clot-Immune Complex via Modulating Fibrin Network.

Authors:  Shiyu Wu; Zhengjie Shan; Lv Xie; Mengxi Su; Peisheng Zeng; Peina Huang; Lingchan Zeng; Xinyue Sheng; Zhipeng Li; Gucheng Zeng; Zhuofan Chen; Zetao Chen
Journal:  Adv Sci (Weinh)       Date:  2021-11-24       Impact factor: 16.806

4.  Development of 3D Printed Biodegradable Mesh with Antimicrobial Properties for Pelvic Organ Prolapse.

Authors:  Jiongyu Ren; Rebecca Murray; Cynthia S Wong; Jilong Qin; Michael Chen; Makrina Totsika; Andrew D Riddell; Andrea Warwick; Nicholas Rukin; Maria A Woodruff
Journal:  Polymers (Basel)       Date:  2022-02-16       Impact factor: 4.329

Review 5.  Tissue-engineered repair material for pelvic floor dysfunction.

Authors:  Meina Lin; Yongping Lu; Jing Chen
Journal:  Front Bioeng Biotechnol       Date:  2022-09-06

Review 6.  Role of Fibroblasts and Myofibroblasts on the Pathogenesis and Treatment of Pelvic Organ Prolapse.

Authors:  Zeliha Guler; Jan Paul Roovers
Journal:  Biomolecules       Date:  2022-01-06

7.  Thermally induced self-agglomeration 3D scaffolds with BMP-2-loaded core-shell fibers for enhanced osteogenic differentiation of rat adipose-derived stem cells.

Authors:  Shuying Hu; Hanbang Chen; Xuefeng Zhou; Gang Chen; Ke Hu; Yi Cheng; Lili Wang; Feimin Zhang
Journal:  Int J Nanomedicine       Date:  2018-07-17
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.